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82.9% for maximal sterile barrier precaution, 100.0% for the use of CHG,
83.4% for optimal site selection.
Conclusions: The surveillance study to find out the specific bundles with low
compliance should be warranted.PS 1-052
EFFECTIVENESS OF ELECTRONIC LEARNING ON URINARY CATHETER
CARE IN AN ACUTE TERTIARY HOSPITAL
K. Y. Tan, H. X. Toh, F. Ibrahim, M. L. Ling. Infection Control, Singapore
General Hospital, Singapore
Purpose: Catheter-associated urinary tract infection (CAUTI) accounts for
30% to 40% of healthcare associated infection (HAI). Indwelling urinary cath-
eter causes pain and discomfort, which might lead to prolonged hospitalisa-
tion stay. The ongoing care of an indwelling urinary catheter lies with the
nurses. In order to improve the quality of care in urinary catheter, the inter-
vention measures in infection control plays an important role. The Infection
Control Department implemented CAUTI electronic learning module to
educate nurses with the objective to increase their awareness and knowl-
edge in the care of urinary catheter.
Methods: The cohort study was conducted over a period of 3 months in two
wards- medical and surgical wards. The content of the module comprise CAUTI
insertion andmaintenancebundlesadopted fromCDCguidelines.Apreandpost
survey as well as a weekly audit on the care on urinary catheter were used to
evaluate the effectiveness of the electronic learning among the nurses.
Results: A total of 87.7% nurses responded. The findings showed improve-
ment in knowledge from a mean score of 17.2 to 18.3 among the surgical
discipline (p Z 0.008) and an improved mean score of 14.8 to 15.7 among
the medical discipline (pZ0.008). Using Fishers’exact test the results shown
an improvement in the audit compliance rate from 83% to 90% (pZ 1.000) in
surgical discipline and 60% to 79.7% in medical discipline (p Z 0.176).
Conclusion: From the results, the nurses have shown improvement in their
knowledge on the care of urinary catheter. With the success of this cohort
study, we intend to launch the CAUTI electronic learning module throughout
the hospital.PS 1-053
CONTROL CATHETER-ASSOCIATED URINARY TRACT INFECTIONS IN A
NEUROSURGERY INTENSIVE CARE UNIT
Wei-Ya Cheng. Department of Nursing, Chi Mei Medical Center, Liouying,
Tainan, Taiwan
Purpose: This study was conducted to evaluate the effect of the implemen-
tation of one catheter-associated urinary tract infection (CAUTI) care bundle
in the neurosurgery intensive care unit (NSI-ICU).Methods: This study was carried in a NS-ICU at regional teaching hospital
that has 10 adult ICU beds. Since July, 2013, the CAUTI care bundle was
implemented in the entire ICU. The bundle includes several components
including hand hygiene, ensuring that there are the indications for urinary
catheter insertion, use of aseptic technique by trained healthcare providers,
maintenance of a sterile closed drainage system, keeping the drainage bag
below the level of bladder, daily review the indications for the urinary cath-
eter, early removal of unnecessary catheters, and avoiding routine changing
of catheters or drainage bags. Outcomes including CAUTI per 1,000 catheter-
days, CAUTI per 1,000 inpatient-days, and catheter utilization rates (days of
catheter use divided by total inpatient-days) were measured.
Results: During the 2-year period, there were a total of 16 episodes of CAUTI
and the catheter utilization rate was 0.83. The rate of CAUTI was 2.13 per
1,000 inpatient-days and 2.55 per 1,000 catheter-days. The rate ofCAUTI signif-
icantly declined from 3.86 per 1,000 catheter-days in Pre-P to 0 per 1,000 cath-
eter-days in Post-P3 (p Z 0.026). In addition, the rate of CAUTI per 1,000
inpatient-days showed a similar trend that significantly decreased from 3.01
per 1,000 inpatient-days in Pre-P to 0 per 1,000 inpatient-days (pZ 0.037).
Conclusion: The rate of CAUTI in NS-ICU can be reduced to zero after imple-
mentation of a prevention care bundle.PS 1-054
EFFICACY AND TOLERABILITY OF CEFTOBIPROLE MEDOCARIL IN CHINA,
SOUTH KOREA, AND TAIWAN: POST-HOC ANALYSIS OF TWO RANDOMIZED
TRIALS IN COMMUNITY-ACQUIRED AND HOSPITAL-ACQUIRED PNEUMONIA
Yin-Ching Chuang a, Mikael Saulay b, David Main c, Marc Engelhardt c,
Achim Kaufhold c. aChi-Mei Medical Center, Tainan City, Taiwan; bAptiv
Solutions, Allschwil, Switzerland; cBasilea Pharmaceutica International Ltd,
Basel, Switzerland
Purpose: A post hoc analysis was undertaken of 2 global randomized, double-
blind Phase 3 studies in community-acquired pneumonia (CAP) or hospital-ac-
quired pneumonia (HAP [including ventilator-associated pneumonia]) to deter-
mine the efficacy and tolerability of ceftobiprole medocaril vs comparators in
patients enrolled in China, South Korea, and Taiwan. Ceftobiprole medocaril
is the prodrug of ceftobiprole, a novel cephalosporin for intravenous use with
activity against Gram-positive pathogens, including methicillin-resistant S.
aureus (MRSA) and against Gram-negative pathogens, including P. aeruginosa.
Methods: In the CAP study, patients were randomized to 5e14 days ceftobi-
prole 500 mg q8h or ceftriaxone 2000 mg once daily  linezolid 600 mg q12h.
In the HAP study, patients were randomized to 7e14 days ceftobiprole 500
mg q8h or combined ceftazidime 2000 mg q8h + linezolid 600 mg q12h. In
both studies, ceftobiprole and comparators were evaluated for clinical cure
at the test-of-cure (TOC) visit, 30-day pneumonia specific mortality (PSM)
and all-cause mortality (ACM) using the intent-to-treat population and micro-
biological eradication using the microbiologically evaluable population.
Results: 139/638 patients in CAP and 82/781 patients in HAP (16% of the
study populations) were included in this analysis. In CAP, cure rates were
73.5% with ceftobiprole and 70.4% with ceftriaxone  linezolid. Microbiolog-
ical eradication was numerically higher with ceftobiprole (92.9% vs 80.0%),
and 30-day mortality was numerically lower (ACM: 1.5% vs 2.8%; PSM: 0%
vs 1.4%). In HAP, cure rates were 46.3% in the ceftobiprole and ceftazi-
dime/linezolid groups. Microbiological eradication was numerically higher
(38.9% vs 21.1%), and 30-day mortality was numerically lower (ACM 7.3% vs
14.6%; PSM 2.4% vs 7.3%) with ceftobiprole. Adverse events were comparable
between treatments.
Conclusion: In this post hoc analysis of patients enrolled from 3 Asian coun-
tries, ceftobiprole medocaril was effective and well tolerated vs treatment
with ceftriaxone  linezolid in CAP and vs ceftazidime plus linezolid in HAP.PS 1-055
TO USE CVC BUNDLE CARE IMPROVEMENT CRBSI EXPERIENCE
Li-Hung Wu a, Yu-Ho Hsieh b, Ya-Fang Chang b, Yu-Ting Wang b,
She-Chiung Ke b, Chia-Chi Hsieh b, Hui-Chun Hsieh b, Mei Chuang c.
aInfection Control Office, Show Chwan Memorial Hospital, Taiwan;
bDepartment of Nursing, Show Chwan Memorial Hospital, Taiwan; cDivision
of Infection Diseases, Show Chwan Memorial Hospital, Taiwan
Purpose: As the care unit for the General Department of our hospital, the
Intensive Care Unit got its rate of BSI go up to 9.4% in 2012 from the 10.3%
